NAV as on 21-02-2025
AUM as on 31-12-2024
Rtn ( Since Inception )
19.75%
Inception Date
Feb 06, 2024
Expense Ratio
2.39%
Fund Status
Open Ended Scheme
Min. Investment
100
Min. Topup
100
Min. SIP Amount
0
Risk Status
very high
Investment Objective : The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.